Bionano Genomics, Inc.BNGO
Price (close)
$1.66
Market cap
$19.5M
P/E
—
Revenue (TTM)
$30.2M
Net income
-$32.2M
Dividend yield
—
1-year total return
-2.9%
Net margin
-106.6%
Revenue growth
10.0%
Debt / equity
—
What Bionano Genomics, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $8.5M | $18.0M | $27.8M | $36.1M | $30.8M | $28.5M |
| Net income | -$41.1M | -$72.4M | -$132.6M | -$232.5M | -$112.0M | -$26.4M |
| Free cash flow | -$38.3M | — | — | — | — | — |
More on BNGO.
- Bionano Genomics, Inc. summary
- Bionano Genomics, Inc. financial statements
- Bionano Genomics, Inc. key metrics
- Bionano Genomics, Inc. health scores and style box
- Bionano Genomics, Inc. earnings
- Bionano Genomics, Inc. dividends
- Bionano Genomics, Inc. valuation
- Bionano Genomics, Inc. ownership and insiders
- Bionano Genomics, Inc. peers
Figures from Bionano Genomics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.